Results 131 to 140 of about 28,273 (262)

Mini-laparotomy versus transrectal natural orifice specimen extraction for minimally invasive colorectal cancer surgery: study protocol for a randomized controlled trial (MINITR-NOSE trial, TCAR2514 protocol). [PDF]

Trials
Lo AL, Hsu YJ, Chern YJ, Cheng CC, Jong BK, Yu ZH, Chan LY, You JF, NOSE study group of Taiwan Colorectal Action Research Society.   +8 more
europepmc   +1 more source

Patient‐Reported Dysphagia and Swallowing‐Related Quality of Life up to 10 Years After (Chemo)radiotherapy for Head and Neck Cancer: A Cross‐Sectional Study

Head &Neck, EarlyView.
ABSTRACT Background This study sought to better understand patient‐reported dysphagia and swallowing‐related quality of life (swQOL) in patients 6 months to 10 years following definitive (chemo)radiotherapy for head and neck cancer (HNC). Methods In this cross‐sectional study, self‐reported dysphagia was assessed with the Eating Assessment Tool (EAT‐10)
Jacqui J. Frowen, Allison Drosdowsky, Tsien F. Fua, Lachlan J. McDowell, Karla Gough   +4 more
wiley   +1 more source

Role of additional topotecan injections (plus two) in reducing recurrence rate in retinoblastoma of group D and group E patients: a retrospective study. [PDF]

BMJ Open Ophthalmol
Lin X, Zheng Z, Chen H, Qian J, Liu Q, Ma R, Xue K.   +6 more
europepmc   +1 more source

Loss of the Y Chromosome in Oral Potentially Premalignant Disorders Predicts Malignant Progression: An Integrative Cross‐Species Multi‐Cohort Bioinformatic Study

Head &Neck, EarlyView.
ABSTRACT Background The loss of the Y chromosome (LOY) and the extreme down‐regulation of Y chromosome gene expression (EDY) are frequently observed in oral squamous cell carcinoma (OSCC). However, their roles in oral potentially malignant disorders (OPMDs) are unclear.
Rui Han, Jos B. Poell, Cristina Conde‐Lopez, Tuula Salo, Ina Kurth, Ruud H. Brakenhoff, Jochen Hess   +6 more
wiley   +1 more source

Multidisciplinary approach to atypical parathyroid tumours and severe hypercalcemia: a case report. [PDF]

AME Case Rep
Giannopoulos NG, Colella A, Goel S, Bird J, Foreman A, Krishnan S, Hodge JC.   +6 more
europepmc   +1 more source

Malignant Transformation of Oral Leukoplakia and Proliferative Verrucous Leukoplakia and Its Biomarker Predictors: A Systematic Umbrella Review

Head &Neck, EarlyView.
ABSTRACT Background Oral leukoplakia (OL) represents the most common oral potentially malignant disorder globally, with highly variable reported malignant transformation (MT) rates creating challenges for evidence‐based clinical management. Objective To systematically synthesize evidence on MT prevalence in OL and evaluate potential predictive ...
Mohammed Taib Fatih, Mohammed Khalid Mahmood, Balkees Taha Garib, Yad Mariwan Mohammed Amin, Ranjdar Mahmood Talabani, Tara Ali Rasheed, Handren Ameer Kurda, Balen Hamid Qadir, Zana Fuad Noori, Mohammed Aso Abdulghafor, Ariwan Othman Saeed, Herve Tassery, Delphine Tardivo, Romain Lan   +13 more
wiley   +1 more source

Utility of Volatile Organic Compounds and Electronic Nose Technology for Breast Cancer Detection: A Systematic Review. [PDF]

Breast Cancer (Dove Med Press)
Orduña-Medina FM, Díaz de León-Martinez L, Alarcón-Rivera GDD, Prieto-Gómez NA, Mizaikoff B, Alcántara-Quintana LE.   +5 more
europepmc   +1 more source

Genomic and Immune Correlates of EZH2 Expression and Activity in Olfactory Neuroblastoma

Head &Neck, EarlyView.
ABSTRACT Purpose Olfactory neuroblastoma (ONB) is a rare sinonasal malignancy with limited therapeutic options in the recurrent/metastatic setting; little is known regarding its responsiveness to immunotherapy. Inhibition of enhancer of zeste homolog 2 (EZH2) has been shown to improve T‐cell‐mediated killing and susceptibility to immune checkpoint ...
Elisabetta Xue, Tolulope Adeyelu, Harris Krause, Andrew Elliott, Ranee Mehra, Heloisa Soares, Emil Lou, Ari Vanderwalde, David Spetzler, Dara Bracken‐Clarke, Nyall R. London Jr., James L. Gulley, Charalampos S. Floudas   +12 more
wiley   +1 more source

Giant cell tumor of the temporal bone: two case reports and literature review. [PDF]

Arch Craniofac Surg
Abderrahmen K, Ghedira K, Zehani A, Kedous S, Bouali S.   +4 more
europepmc   +1 more source

Neoadjuvant Immunotherapy for Periauricular Cutaneous Squamous Cell Carcinoma

Head &Neck, EarlyView.
ABSTRACT Background The standard‐of‐care for advanced periauricular cutaneous squamous cell carcinoma (pCSCC) is surgery and adjuvant radiation therapy. Neoadjuvant immunotherapy recently demonstrated high pathologic response rates in patients with resectable pCSCC.
David Z. Allen, Neil Gross, Marc‐Elie Nader, Renata Ferrarotto, Moran Amit, Priyadharsini Nagarajan, Paul Gidley   +6 more
wiley   +1 more source